Diverse chemotypes drive biased signaling by cannabinoid receptors

Nov 11, 2020

1 min read

Our latest BioRxiv preprint describing a set of 35 cannabinoid ligands with full ADME properties dialling the signalling bias in a rheostat-like manner.

https://doi.org/10.1101/2020.11.09.375162

Congratulations Tamara!

Recent Posts

See All

Fully funded PhD. Developing quantum biosensing GPCR drug discovery platform.

G protein coupled receptor coordinate functions of our body by transmitting extracellular hormonal to the inside of the cell. GPCRs offer...

PhD project. GPCR on-a-chip: quantum biosensor for drug discovery

The goal of this project is to develop quantum biosensors for drug discovery at single molecule level. Quantum sensing detects changes in...

PhD project: Role of GPCR autoantibodies in auto-immune hepatitis

Short read: The project is focused on identification of autoantibodies against a panel of inflammation related GPCRs in patient samples...

Comments